Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Natural killer cell differentiation"'
Autor:
Pierre Milpied, Arnaud Villacreces, Christelle Piperoglou, Eric Vivier, Frédéric Vély, Laurine Gil, Adeline Crinier, Pierre-Yves Dumas, Zoran Ivanovic, Emilie Narni-Mancinelli, Bertrand Escalière
Publikováno v:
Cellular and molecular immunology
Cellular and molecular immunology, Nature Publishing Group/Chinese Society of Immunology, 2021, ⟨10.1038/s41423-021-00771-z⟩
Cellular and molecular immunology, 2020, ⟨10.1038/s41423-020-00574-8⟩
Cellular and molecular immunology, Nature Publishing Group/Chinese Society of Immunology, 2020, ⟨10.1038/s41423-020-00574-8⟩
Cellular and molecular immunology, 2021, ⟨10.1038/s41423-021-00771-z⟩
Cell Mol Immunol
Cellular and Molecular Immunology
Cellular & Molecular Immunology
Cellular and molecular immunology, Nature Publishing Group/Chinese Society of Immunology, 2021, ⟨10.1038/s41423-021-00771-z⟩
Cellular and molecular immunology, 2020, ⟨10.1038/s41423-020-00574-8⟩
Cellular and molecular immunology, Nature Publishing Group/Chinese Society of Immunology, 2020, ⟨10.1038/s41423-020-00574-8⟩
Cellular and molecular immunology, 2021, ⟨10.1038/s41423-021-00771-z⟩
Cell Mol Immunol
Cellular and Molecular Immunology
Cellular & Molecular Immunology
SummaryNatural killer (NK) cells are innate cytotoxic lymphoid cells (ILCs) involved in the killing of infected and tumor cells. Among human and mouse NK cells from the spleen and blood, we previously identified by single-cell RNA sequencing (scRNAse
Autor:
Peter O Oluoch, Ann M. Moormann, Lara Zuppiger, Nicole Caduff, Thomas F. Schulz, David J. Blackbourn, Lisa Rieble, Christian Münz, Anita Murer, Ana Raykova, Obinna Chijioke, Donal McHugh, John M. Ong’echa, Catherine Forconi, Michelle Böni
Publikováno v:
Cell Reports, Vol 35, Iss 5, Pp 109056-(2021)
Summary Herpesvirus infections shape the human natural killer (NK) cell compartment. While Epstein-Barr virus (EBV) expands immature NKG2A+ NK cells, human cytomegalovirus (CMV) drives accumulation of adaptive NKG2C+ NK cells. Kaposi sarcoma-associat
Publikováno v:
Cell Mol Immunol
CELLULAR & MOLECULAR IMMUNOLOGY, 18(5), 1348-1349. CHIN SOCIETY IMMUNOLOGY
CELLULAR & MOLECULAR IMMUNOLOGY, 18(5), 1348-1349. CHIN SOCIETY IMMUNOLOGY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b96034e52f99b9a6d589920a1ed39a9f
https://hdl.handle.net/1887/3196223
https://hdl.handle.net/1887/3196223
Autor:
Steven E. Bosinger, Jeffrey D. Lifson, Kirk Easley, Francois Villinger, Hong Wang, Philippe Rascle, Luca Micci, Guido Silvestri, Neeta Shenvi, Gregory K. Tharp, Nicolas Huot, Cristin M. Galardi, Colin T. King, Michaela Müller-Trutwin, Justin L. Harper, Amit A. Upadhyay, Beatrice Jacquelin, Mirko Paiardini
Publikováno v:
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2866. ⟨10.1038/s41467-021-23189-7⟩
Nature Communications, 2021, 12 (1), pp.2866. ⟨10.1038/s41467-021-23189-7⟩
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2866. ⟨10.1038/s41467-021-23189-7⟩
Nature Communications, 2021, 12 (1), pp.2866. ⟨10.1038/s41467-021-23189-7⟩
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Unlike HIV infection, which progresses to AIDS absent suppressive anti-retroviral therapy, nonpathogenic infections in natural hosts, such African green monkeys, are characterized by a lack of gut microbial translocation and robust secondary lymphoid
Autor:
Anita Murer, Lisa Rieble, Michael Ongecha, Obinna Chijioke, Thomas F. Schulz, Catherine Forconi, Ana Raykova, David J. Blackbourn, Donal McHugh, Christian Münz, Nicole Caduff, Peter O Oluoch, Ann M. Moormann
Publikováno v:
SSRN Electronic Journal.
Herpesvirus infections shape the human natural killer (NK) cell compartment. While the Epstein Barr virus (EBV) expands immature NKG2A+ NK cells, the human cytomegalovirus (CMV) drives accumulation of adaptive NKG2C+ NK cells. Kaposi sarcoma-associat
Autor:
Marc Brillantes, Aimee M. Beaulieu
Publikováno v:
Immunology. 156:111-119
Natural killer (NK) cells are highly specialized cytotoxic lymphocytes that provide protection against pathogens and malignant cells. They develop from common lymphoid progenitors via a multi-stage lineage commitment and differentiation process that
Autor:
Angela R. Manser, Gesine Kögler, Lutz Walter, Markus Uhrberg, Sandra Weinhold, Sabrina Bianca Bennstein, Nadine Scherenschlich
Publikováno v:
Stem Cells Translational Medicine, Vol 8, Iss S1, Pp S11-S11 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e400a60ba22d7412d6ec1fe26d7f21
https://europepmc.org/articles/PMC6713548/
https://europepmc.org/articles/PMC6713548/
Autor:
Jodie P. Goodridge, Ebba Sohlberg, Eivind Heggernes Ask, Aline Pfefferle, Herman Netskar, Trevor Clancy, Suzanne Lorenz, Karl-Johan Malmberg
Natural killer cell repertoires are functionally diversified as a result of differentiation, homeostatic receptor-ligand interactions and adaptive responses to viral infections. However, the regulatory gene-circuits that define the manifold cell stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6358625dab4e6fd9514f8425cc8b7f
https://doi.org/10.1101/630657
https://doi.org/10.1101/630657
Publikováno v:
Genomics, Proteomics & Bioinformatics
Natural killer (NK) cells are essential in controlling cancer and infection. However, little is known about the dynamics of the transcriptional regulatory machinery during NK cell differentiation. In this study, we applied assay of transposase access
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::001dea93e830c02ce78c50d1f2b38ae4
Autor:
Jana Führing, John Post, Françoise H. Routier, David W. Gray, Sharon M. Shepherd, Ohm Prakash, Thomas C. Eadsforth, Roman Fedorov
Publikováno v:
Molecules, Vol 24, Iss 5, p 996 (2019)
Molecules
Volume 24
Issue 5
Molecules
Volume 24
Issue 5
Leishmaniasis is a neglected disease that is caused by different species of the protozoan parasite Leishmania, and it currently affects 12 million people worldwide. The antileishmanial therapeutic arsenal remains very limited in number and efficacy,